Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Minakem (Minafin Group) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Belgium
Founded:2016
Employees:1,393
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Minakem Beuvry Production
145, Chemin des Lilas, Beuvry la Foret, 59310
Site Capabilities
2 capabilitiesANALYSIS
API MANUFACTURE
Regulatory Approvals
Drug Approval SPFL5F
PMDA · #APR-Z649118H · 2019-06-01
Certifications
WHO GMP
World Health Organization
Cert #: CERT-TJMR5M3Z
Issued: 2020-04-10
Expires: 2025-09-23
Health Canada GMP
Health Canada
Cert #: CERT-ZHQ1SUIP
Issued: 2020-10-26
Expires: 2025-01-15
Loading CDMO intelligence...
Key facts about Minakem (Minafin Group)
- Minakem (Minafin Group) is headquartered in Belgium.
- Minakem (Minafin Group) was founded in 2016.
- Minakem (Minafin Group) has 1,393 employees.
- Minakem (Minafin Group) has one manufacturing site listed on CDMO Hub, in Beuvry la Foret, France.
- Minakem (Minafin Group)'s capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Minakem (Minafin Group)
Directory pages this company appears in, each with the full list of matching manufacturers.